Crossmark

Inhibition of esophageal squamous cell carcinoma progression by MIR210HG and activation of the P53 signaling pathway to promote apoptosis and autophagy

Crossref DOI link: https://doi.org/10.1186/s40001-025-02512-8

Published Online: 2025-04-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Jianyu

Zhang, Zhenhu

Song, Liang

Liu, Xiangyan

He, Xiaopeng
License Information

Text and Data Mining valid from 2025-04-11

Version of Record valid from 2025-04-11
More Information

Article History

Received: 27 October 2024

Accepted: 26 March 2025

First Online: 11 April 2025

Declarations

:

: The study was approved by the Ethical Review Committee of Shandong Provincial hospital affiliated to Shandong First Medical University (approval number: No. NSFC 2024 - 613).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below